FDA Inspection 547918 — Astellas Pharma US Inc.

Astellas Pharma US Inc. — FEI 1000036852

The FDA completed an inspection of Astellas Pharma US Inc. on November 20, 2008 in Northbrook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 20, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Northbrook, IL (United States)